Exact Mass: 507.18662759999995
Exact Mass Matches: 507.18662759999995
Found 138 metabolites which its exact mass value is equals to given mass value 507.18662759999995
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(2E)-3-[2,3-dihydro-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-1,4-benzodioxin-6-yl]-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide|thoreliamide B
Ala Cys Glu Trp
C22H29N5O7S (507.17876040000004)
Ala Cys Trp Glu
C22H29N5O7S (507.17876040000004)
Ala Glu Cys Trp
C22H29N5O7S (507.17876040000004)
Ala Glu Trp Cys
C22H29N5O7S (507.17876040000004)
Ala Trp Cys Glu
C22H29N5O7S (507.17876040000004)
Ala Trp Glu Cys
C22H29N5O7S (507.17876040000004)
Cys Ala Glu Trp
C22H29N5O7S (507.17876040000004)
Cys Ala Trp Glu
C22H29N5O7S (507.17876040000004)
Cys Glu Ala Trp
C22H29N5O7S (507.17876040000004)
Cys Glu Trp Ala
C22H29N5O7S (507.17876040000004)
Cys Trp Ala Glu
C22H29N5O7S (507.17876040000004)
Cys Trp Glu Ala
C22H29N5O7S (507.17876040000004)
Asp Gly Met Trp
C22H29N5O7S (507.17876040000004)
Asp Gly Trp Met
C22H29N5O7S (507.17876040000004)
Asp Met Gly Trp
C22H29N5O7S (507.17876040000004)
Asp Met Trp Gly
C22H29N5O7S (507.17876040000004)
Asp Asn Pro Tyr
C22H29N5O9 (507.19651840000006)
Asp Asn Tyr Pro
C22H29N5O9 (507.19651840000006)
Asp Pro Asn Tyr
C22H29N5O9 (507.19651840000006)
Asp Pro Tyr Asn
C22H29N5O9 (507.19651840000006)
Asp Ser Thr Trp
C22H29N5O9 (507.19651840000006)
Asp Ser Trp Thr
C22H29N5O9 (507.19651840000006)
Asp Thr Ser Trp
C22H29N5O9 (507.19651840000006)
Asp Thr Trp Ser
C22H29N5O9 (507.19651840000006)
Asp Trp Gly Met
C22H29N5O7S (507.17876040000004)
Asp Trp Met Gly
C22H29N5O7S (507.17876040000004)
Asp Trp Ser Thr
C22H29N5O9 (507.19651840000006)
Asp Trp Thr Ser
C22H29N5O9 (507.19651840000006)
Asp Tyr Asn Pro
C22H29N5O9 (507.19651840000006)
Asp Tyr Pro Asn
C22H29N5O9 (507.19651840000006)
Glu Ala Cys Trp
C22H29N5O7S (507.17876040000004)
Glu Ala Trp Cys
C22H29N5O7S (507.17876040000004)
Glu Cys Ala Trp
C22H29N5O7S (507.17876040000004)
Glu Cys Trp Ala
C22H29N5O7S (507.17876040000004)
Glu Ser Ser Trp
C22H29N5O9 (507.19651840000006)
Glu Ser Trp Ser
C22H29N5O9 (507.19651840000006)
Glu Trp Ala Cys
C22H29N5O7S (507.17876040000004)
Glu Trp Cys Ala
C22H29N5O7S (507.17876040000004)
Glu Trp Ser Ser
C22H29N5O9 (507.19651840000006)
Gly Asp Met Trp
C22H29N5O7S (507.17876040000004)
Gly Asp Trp Met
C22H29N5O7S (507.17876040000004)
Gly Met Asp Trp
C22H29N5O7S (507.17876040000004)
Gly Met Trp Asp
C22H29N5O7S (507.17876040000004)
Gly Trp Asp Met
C22H29N5O7S (507.17876040000004)
Gly Trp Met Asp
C22H29N5O7S (507.17876040000004)
b-D-Glucopyranosiduronic acid, 4-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-2-methoxyphenyl, (3S-tr
5-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-2-methoxy-, (3S-trans)-Phenol glucuronide
Met Asp Gly Trp
C22H29N5O7S (507.17876040000004)
Met Asp Trp Gly
C22H29N5O7S (507.17876040000004)
Met Gly Asp Trp
C22H29N5O7S (507.17876040000004)
Met Gly Trp Asp
C22H29N5O7S (507.17876040000004)
Met Trp Asp Gly
C22H29N5O7S (507.17876040000004)
Met Trp Gly Asp
C22H29N5O7S (507.17876040000004)
Asn Asp Pro Tyr
C22H29N5O9 (507.19651840000006)
Asn Asp Tyr Pro
C22H29N5O9 (507.19651840000006)
Asn Pro Asp Tyr
C22H29N5O9 (507.19651840000006)
Asn Pro Tyr Asp
C22H29N5O9 (507.19651840000006)
Asn Tyr Asp Pro
C22H29N5O9 (507.19651840000006)
Asn Tyr Pro Asp
C22H29N5O9 (507.19651840000006)
Pro Asp Asn Tyr
C22H29N5O9 (507.19651840000006)
Pro Asp Tyr Asn
C22H29N5O9 (507.19651840000006)
Pro Asn Asp Tyr
C22H29N5O9 (507.19651840000006)
Pro Asn Tyr Asp
C22H29N5O9 (507.19651840000006)
Pro Tyr Asp Asn
C22H29N5O9 (507.19651840000006)
Pro Tyr Asn Asp
C22H29N5O9 (507.19651840000006)
Ser Asp Thr Trp
C22H29N5O9 (507.19651840000006)
Ser Asp Trp Thr
C22H29N5O9 (507.19651840000006)
Ser Glu Ser Trp
C22H29N5O9 (507.19651840000006)
Ser Glu Trp Ser
C22H29N5O9 (507.19651840000006)
Ser Ser Glu Trp
C22H29N5O9 (507.19651840000006)
Ser Ser Trp Glu
C22H29N5O9 (507.19651840000006)
Ser Thr Asp Trp
C22H29N5O9 (507.19651840000006)
Ser Thr Trp Asp
C22H29N5O9 (507.19651840000006)
Ser Trp Asp Thr
C22H29N5O9 (507.19651840000006)
Ser Trp Glu Ser
C22H29N5O9 (507.19651840000006)
Ser Trp Ser Glu
C22H29N5O9 (507.19651840000006)
Ser Trp Thr Asp
C22H29N5O9 (507.19651840000006)
Thr Asp Ser Trp
C22H29N5O9 (507.19651840000006)
Thr Asp Trp Ser
C22H29N5O9 (507.19651840000006)
Thr Ser Asp Trp
C22H29N5O9 (507.19651840000006)
Thr Ser Trp Asp
C22H29N5O9 (507.19651840000006)
Thr Trp Asp Ser
C22H29N5O9 (507.19651840000006)
Thr Trp Ser Asp
C22H29N5O9 (507.19651840000006)
Trp Ala Cys Glu
C22H29N5O7S (507.17876040000004)
Trp Ala Glu Cys
C22H29N5O7S (507.17876040000004)
Trp Cys Ala Glu
C22H29N5O7S (507.17876040000004)
Trp Cys Glu Ala
C22H29N5O7S (507.17876040000004)
Trp Asp Gly Met
C22H29N5O7S (507.17876040000004)
Trp Asp Met Gly
C22H29N5O7S (507.17876040000004)
Trp Asp Ser Thr
C22H29N5O9 (507.19651840000006)
Trp Asp Thr Ser
C22H29N5O9 (507.19651840000006)
Trp Glu Ala Cys
C22H29N5O7S (507.17876040000004)
Trp Glu Cys Ala
C22H29N5O7S (507.17876040000004)
Trp Glu Ser Ser
C22H29N5O9 (507.19651840000006)
Trp Gly Asp Met
C22H29N5O7S (507.17876040000004)
Trp Gly Met Asp
C22H29N5O7S (507.17876040000004)
Trp Met Asp Gly
C22H29N5O7S (507.17876040000004)
Trp Met Gly Asp
C22H29N5O7S (507.17876040000004)
Trp Ser Asp Thr
C22H29N5O9 (507.19651840000006)
Trp Ser Glu Ser
C22H29N5O9 (507.19651840000006)
Trp Ser Ser Glu
C22H29N5O9 (507.19651840000006)
Trp Ser Thr Asp
C22H29N5O9 (507.19651840000006)
Trp Thr Asp Ser
C22H29N5O9 (507.19651840000006)
Trp Thr Ser Asp
C22H29N5O9 (507.19651840000006)
Tyr Asp Asn Pro
C22H29N5O9 (507.19651840000006)
Tyr Asp Pro Asn
C22H29N5O9 (507.19651840000006)
Tyr Asn Asp Pro
C22H29N5O9 (507.19651840000006)
Tyr Asn Pro Asp
C22H29N5O9 (507.19651840000006)
Tyr Pro Asp Asn
C22H29N5O9 (507.19651840000006)
Tyr Pro Asn Asp
C22H29N5O9 (507.19651840000006)
Quinacrine Dihydrochloride Dihydrate
C23H36Cl3N3O3 (507.1822116000001)
(S,E)-ETHYL 7-(4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-(N-METHYLMETHYLSULFONAMIDO)PYRIMIDIN-5-YL)-5-HYDROXY-3-OXOHEPT-6-ENOATE
C24H30FN3O6S (507.18392520000003)
2-[(1E,3Z)-3-CYANO-5-(1,3,3-TRIMETHYL-1,3-DIHYDRO-2H-INDOL-2-YLIDENE)-1,3-PENTADIENYL]-1,3,3-TRIMETHYL-3H-INDOLIUM PERCHLORATE
C28H30ClN3O4 (507.19247300000006)
CLEBOPRIDE malATE
C24H30ClN3O7 (507.17721800000004)
C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist Clebopride malate is a dopamine antagonist used in the study of functional gastrointestinal disorders.
1,3,5-tris[3-(pyridin-4-yl)-1H-pyrazol-1-yl]benzene
SRT 1460
C26H29N5O4S (507.19401540000007)
SRT 1460, a potent Sirtuin-1 (SIRT1) activator with an EC1.5 value of 2.9 μM, shows good selectivity for activation of SIRT1 versus SIRT2 and SIRT3 (EC1.5>300 μM), and is more potent than Resveratrol and the closest sirtuin homologues[1].
Umeclidinium Bromide
C29H34BrNO2 (507.17727640000004)
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BB - Anticholinergics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent Umeclidinium bromide is a novel mAChR antagonist. The affinity (Ki) of Umeclidinium bromide for the cloned human M1-M5 mAChRs ranges from 0.05 to 0.16 nM.
2-[[[2-Amino-1-(3-methoxypropyl)-3-pyrrolo[3,2-b]quinoxalinyl]-oxomethyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid ethyl ester
C26H29N5O4S (507.19401540000007)
N-alpha-(2-Naphthylsulfonyl)-N(3-amidino-L-phenylalaninyl)-4-acetyl-piperazine
C26H29N5O4S (507.19401540000007)
(E)-1-(glutathion-S-yl)-N-hydroxy-omega-(methylsulfanyl)nonan-1-imine
(1R,2R,5S,8S,9S,10R,11R,12S)-5-hydroxy-11-methyl-6-methylidene-16-oxo-12-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadec-13-ene-9-carboxylate
C25H31O11- (507.18662759999995)
gibberellin A3 O-beta-D-glucoside(1-)
C25H31O11- (507.18662759999995)
N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-thiophenesulfonamide
C24H33N3O5S2 (507.18615280000006)
N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-thiophenesulfonamide
C24H33N3O5S2 (507.18615280000006)
N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide
C24H33N3O5S2 (507.18615280000006)
N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-thiophenesulfonamide
C24H33N3O5S2 (507.18615280000006)
N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide
C24H33N3O5S2 (507.18615280000006)
N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide
C24H33N3O5S2 (507.18615280000006)
Ibiglustat (succinate)
C24H30FN3O6S (507.18392520000003)
Ibiglustat (Venglustat) succinate is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat succinate can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease[1][2].
NTNCB (hydrochloride)
C25H34ClN3O4S (507.1958434000001)
NTNCB (Compound 11) hydrochloride is a potent and selective neuropeptide Y Y5 (NPY Y5) receptor antagonist with a Ki of 8 nM against human Y5[1].